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INTRODUCTION
Most protein-coding genes of higher eukaryotes are interupted
by introns, which are removed from the primary RNA transcript
by a process termed splicing. The bases which form the borders
of introns and exons comprise the sequences essential for mRNA
splicing, carried out by a ribonucleoprotein complex, the
spliceosome. Over the 13 years since the discovery of this type
of intron, several thousand intron/exon junction sequences have
been determined, which has allowed the compliation of consensus
sequences for both the 5' and 3' splice sites (1-3). The
recognition of the splice site by the spliceosome is of fundamental
importance for the accurate expression of genes. The recognition
of splice sites in DNA by computer searches is of importance
for interpreting genomic sequences, and identifying exons in
streches of otherwise undistiguished DNA.
The consensus splice site sequences have therefore been much
examined. Compilations of splice sites over the years have used
increasing numbers of sites to derive a consensus, which in
general has remained unaltered. Although the splicing substrate
is, of course, RNA, most analyses are carried out on DNA, so
I will refer to the sequences in the DNA form (i.e. using T rather
than U). The consensus sequence at the 5' end of introns is:
(A/C)AG GTAAGT
-1 +1
in which the cleavage occurs between the G residues at positions
-1 and + 1. The sequence is the perfect complement of bases
4-12 from the 5' end of the Ul snRNA component of the
spliceosome:
5' ACUUACCUG 3'
which is thought to guide the selection of the 5' cleavage site.
(The complementarity between the first C of the consensus and
the G at base 12 of Ul RNA is possibly not important for splice
site selection (4)).
After cleavage, the 5' end of the intron forms a lariat structure
using a 2' phosphodiester bond to an A residue near to the 3'
end of the intron. The 3' end of the exon is joined to the next
exon, defined by a 3' splice site consensus of:
(Py)nNPyAG G
-1 +1
where cleavage is again between the two G residues.
Most positions of the both consensus sequences are not
invariant; at some positions only 50-60% of splice sites actually
have the consensus base (see below for a discussion of the ways
in which the sites can diverge from the prototype). However,
the first two and the last two bases of the intron are invariant;
which gave rise to the so-called GT-AG rule for splice site
selection (5).
Among the thousands of splice sites analysed by Shapiro et
al a handful were identified which did not conform to the GT-A-
G rule (3). Prompted by the identification of a non-consensus
splice in the murine TRP-1 gene (52) I have reassesed these
previously published non-GT-AG sites, eliminated a number as
clear errors or misinterpretation and identified several more.
Almost all these non-consensus splices now fall into particular
patterns which allow further rules for splice consensus sequences
to be deduced.
A number of immunoglobulin genes appear to have non-
consensus splice sites which do not fall into these patterns.
However, there are problems in determining if particular
immunoglobulin genes are active, and what is the actual genomic
sequence from which the mRNA has been transcribed. I do not
consider any immunoglobulin sequences in this review. Neither
do I consider any yeast (S. cerevisiae) sequences. Yeast introns
are spliced by a mechanism basically the same as in higher
eukaryotes; but with a stronger conservation of branchpoint
sequence and slightly different 5' and 3' consensuses (see 6 for
a recent review).
ELIMINATING ERRORS OF IDENTIFICATION
I have reassesed the non-consensus sites tabulated by Shapiro
et al, by examining the relevant database entry, by examining
the original published data, and in some cases by communication
with relevant labs. The sequences which were thought to be non-
consensus sites but which I have eliminated are shown in Table
1. The grounds for eliminating each sequence are as follows:
5' Splice Sites
a) Chironomus thumni Balbiani ring c locus gene.
The original paper (7) identifies the splice as conforming to a
good consensus match. The site as shown by Shapiro et al has
been placed one base 3' of the correct site.
b) Drosophila opsin gene.
The original paper (8) has all splices conforming to the consensus.
There appears to be an error in database annotation.
c) Human MHC Class II gene.
This gene is described by the authors (9) as a pseudogene, and
its transcript is most likely not processed. Although it does contain
a variant consensus GC sequence (see below) as the first two
. 1991 Oxford University Press
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Table 1. Previously published non-consensus splice sites eliminated in this review.
Genbank gene sequence reason for
locus elimination
5' splice sites
Chibrcb Chironomus Balbiani GAG TAAGTT misalligned I base 3'
ring c locus
Droopsb2 Drosophila opsin GAT TGCCTA database annotation error
Hummhsxa Human MHC class II ATG GCACTG non-functional
pseudogene
Musgfnl Mouse nerve growth GCA TCGGTG database annotation error
factor
Musgfn3 Mouse nerve growth TGC AGAATT database annotation error
factor
Mushoxl62 Mouse Hox-1.6 CAG GGAAGG error in original
published sequence
Droantpg4 Drosophila CAG GAAAGT possible polymorphism
Antennapedia
Hamcryaal Hamster crystallin AGG CAAGTT missalligned base
3' splice sites
Adbcg Adenovirus GGGGTCGTGC A database annotation error
Chibrcg Chironomus Balbiani CGAAAGCAAT G database annotation error
ring c-locus
Chkmyhd Chicken myosin TCCTCTGTCA A incorrect database entry
heavy chain
Humplp4 Human myelin GTTTGTGGGC A database annotation error
proteolipid
Humplp5 Human myelin CCTCTITTCA T database annotation error
proteolipid
Mlap531 Murine leukaemia CTAGTCCCGC T database annotation error
virus iilsertion
Muscd42 Mouse CD4 T-cell GGAGACCACC A atabase annotation error
antigen
Musgstya2 Mouse glutathione AGTTGCTGCA A database and
S-transferase interpretation errors
Muslyt212 Mouse Lyt-2 T-cell GACCTGGACC T interpretation error
antigen
Rattma3 Rat a-tropomyosin AAGAGTTGAA A interpretation error
Sehcryaal Mole rat a-crystalin CCATCAAGGA A interpretation error
bases of the intron, the surrounding sequence is not a good
consensus match and I have neverthiless excluded it from further
consideration.
d) Mouse NGF.
This gene occurs twice in the list of sites, for two splices.
Comparison with the original paper (10) indicates that there has
been a misinterpretation in the database entry, such that intron
and exon sequences have been interchanged. The correctly-
assigned splices have normal consensus splice sites.
e) Mouse Hox-J. 6.
The original publication (11) does not have a consensus 5' site,
and the authors do not comment on it. However, a more recent
sequence (L. Gudas personal communication) shows a T rather
than G at position 2 of the intron, resulting in a consensus splice
site.
f) Drosophila Antennapedia gene.
Analysis of cDNAs from this gene (12) reveals two splice sites,
12 bp apart. When they are alligned on the genomic sequence,
the second of these has GA rather than GT at the 5' end of the
intron. However, the cDNAs analysed were from embryos of
the Oregon R strain of flies, whilst the genomic sequence was
derived from a different strain, Canton S. Schneuwly et al (12)
suggest that there is a polymorphic difference between the two
Table 2. Summary of GC consensus 5' splice sites. The sequence on the top
row is the prototype sequence which is fully complementary to the 5' end of
the Ul snRNA. The gap in the sequences separates exon from intron sequence.
GENE SEQUENCE REFERENCE
prototype CAG GTAAGT
human acetylcholine AAG GCAAGG 28
receptor
human factor XII CCG GCGAGT 29
human factor VII CAG GCGGGG 30
human cytochrome P450 AAG GCAAGC 31
human prothrombin CTG GCAAGT 32
human APRT CAG GCGAGT 33
human keratin GAG GCAGGC 34
human superoxide AAG GCAAGG 35
dismutase
mouse superoxide AAG GCAAG 36
dismutase
hamster at-crystallin AAG GCAAGT 37
mouse a-crystallin AAG GCAAGT 38
mole-rat a-crystallin AAG GCAAGT 39
hamster APRT CAG GCGAGT 40
mouse APRT CAG GCGAGT 41
mouse RNA polymerase II AAG GCATGT 42
mouse RNA polymerase II CAG GCAAGA 42
rat haem oxygenase CAG GCAAGC 43
mouse TRP-1 AAG GCAAGT 52
pig growth hormone CAG GCAAGT 44
bovine aspartyl protease GAG GCAAGT 45
chicken myosin CAG GCAAGT 46
chicken a-globin AAG GCAAGC 47
duck ca-globin AAG GCAAGC 48
earthworm haemoglobin-c CAA GCAAGT 49
neurospora qa repressor TAG GCACGT 50
soybean nodulin-24 AGG GCAAGT 51
strains, the result being that Oregon R embryos use an additional
splice site not present in Canton S. Until more information is
available I exclude this splice from consideration.
g) Syrian golden hamster ot-crystallin gene.
A duplication around the intron site gives ambiguity of location
of this intron. If the intron site is moved lbp 5', the result is
a GC variant consensus splice, identical to that found in the mouse
x-crystallin gene, and I include this hamster gene in Table 2.
The remaining 17 sites described in Shapiro et al, plus the
hamster at-crystallin gene described above, the mole-rat a-
crystallin below and a further 7 sites which I have identified
through literature searches are shown in Table 2 and discussed
in the next section.
3' Sites
a) Adenovirus.
The sequence given as a 3' splice site, is not in fact a site. It
appears to be an error in database annotation; the site given is
found at base 24791 of the sequence, but the actual splice site
is at 24971 (13). The sequence at this site is a consensus 3' AG.
b) Chironomus thummi Balbiani ring c-locus protein.
The site described is not a 3' splice site. There appears to have
been misinterpretation by the database, as the original paper (7)
shows a change in protein domains, not an intron, at the site listed.
c) Chicken myosin heavy chain gene.
In this case there appears to have been incorrect entry of sequence
into the database. The original paper (14) has a G, which is absent
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Table 3. Variants of the 3' splice consensus. The top sequence is the consensus
of all genes (Y = C or T).
GENE SEQUENCE REFERENCE
consensus YYYYYYYYYYNYAG
human Gs-a TTTCAATCCCACTG 22
Drosophila Gs-a TTTCAAATGTGCTG 23
Drosophila per CTTCTCCTCCGCCG 24
Drosophila per CAACGCGTTCGTCG 24
from the database, and which results in the splice being a
consensus 3' AG sequence.
d) Human myelin proteolipid gene.
Two 3' splices in this gene are listed as non-consensus sites. When
the original paper is examined (15) it can be seen that both splices
have been incorrectly annotated in the database, the first splice
is actually 9bp 3' of that shown in the database, the second is
11 bp 5'.
e) Murine leukaemia virus insertion.
This sequence is from an insertion of a retrovirus into an intron
of the p53 gene (16). The sequence is an interuption of an intron
(i.e the point at which the retrovirus has inserted) not the 3' end
of an intron.
f) Mouse CD4 T-cell antigen.
The sequence is not of a splice site but is the junction between
protein encoding and 3' untranslated sequence (17). The database
is incorrectly annotated.
g) Mouse glutathione S-transferase.
The original paper has a consensus 3' splice site (18). The
database also lists a consensus sequence, but it is 14bp 3' of the
one in the paper. The Shapiro listing has yet another site a further
8 bases 3' (and 22 bases 3' of the published splice)
h) Mouse Lyt-2 T-cell differetiation antigen.
This is the end of the sequence of intron B listed in the original
paper (19). Although this sequence is within an intron it is not
the end of the intron. The database is incorrectly annotated.
i) Rat a-tropomyosin.
The sequence shown as a splice is not shown as such in the
original paper (20), nor is it listed as one in the database. The
sequence shown is at base 1176; the nearest genuine 3' splice
site is at 1146. This appears to be an error in the database search.
j) Mole rat a-crystallin.
This is not a 3' splice, but is a 5' splice, with the variant GC
consensus, as in several other mammalian a-crystallin genes. The
database FEATURES table correctly assigns the splice.
The above assessments eliminate all the non-consensus 3' splice
sites tabulated by Shapiro et al (3). I have, however, through
literature searches, identified four variants which cannot be
readily eliminated, and I describe these below.
VARIANT 5' SPLICE SITES
Table 2 lists 26 5' variant splice sites, all of which have GC in
place of the 'invariant' GT at the first two positions of the intron
(positions 1 and 2). Seventeen of these are from the list of Shapiro
Table 4. The 5' and 3' end of the two known splice sites which do not show
any complementarity to the 5' end of the Ul snRNP. Gaps in each sequence
denote the junction between intron and exon or vice versa.
GENE 5' SEQUENCE 3' SEQUENCE REFERENCE
human proliferating cell
nucleolar protein P120 AAT ATATCC GCCCAC ATGCCC 25
chicken cartlige matrix
protein AGG ATATCC ACTCAC TGGAAG 26
et al (3). One has been taken from their list of 3' variant splice
sites (the mole rat a-crystalin gene). An additional GC variant
was identified in the mouse RNA polymerase II gene (which has
two such variants), one has been noted in the mouse TRP-1 gene
(52), three (human keratin, bovine aspartyl protease and
earthworm haemoglobin c) were identified by Medline searches,
and three (human and hamster APRT and mouse super oxide
dismutase) were found by inspecting these sequences at the splice
shown to be variant in other species. Additionally a yeast 5' splice
site with the sequence AAGA/GCATGT was identified (21), but
is not considered further, although yeast genes do have the
'invariant' GT.
Table 4 shows two more splice sites, identified through Medline
search, which are completely different from the prototype
sequence. These are further discussed below.
VARIANT 3' SPLICE SITES
Although all the 3' variants identified by Shapiro et al have been
discounted, further sites have been located by Medline search.
Four of these are shown in Table 3. These are all variants of
the ubiquitous AG at -2 and -1: all contain the G, but vary
at -2 by having a pyrimidine. It is worth noting that all these
variants are alternative splice sites, that is, each gene has a
proportion of transcripts spliced at a consensus AG, and a
proportion at these variants. Interestingly, although the cx-subunit
of the Gs proteins of human and Drosophila both have a TG 3'
site, it is in different alternative introns in either gene (22, 23).
The Drosophila per gene apparently has two CG 3' sites (24).
Table 4 shows two additional sites identified using Medline,
which are the 3' ends of the highly unusual 5' splice sites.
A NOVEL AND RARE SPLICE SITE MOTIF
The two pairs of intron/exon boundary sequences shown in Table
4, from the human proliferating cell nucleolar protein P120 gene
(25) and the chicken cartilage matrix protein gene (26), appear
to represent members of a novel family of splice-site sequences.
Neither show any significant similarity to the prototype 5' site;
but both are identical for at least the first 6 bases of the intron
(ATATCC). Neither have the consensus AG at the 3' end of the
intron, but instead have the sequence CAC.
DISCUSSION
What lessons can be drawn from this study? Firstly, the sequence
databases should not be regarded as error-free. As database input
increases the problem of entry errors will likewise increase. Most
misassignments of splice sites identified in Table 1 were,
however, not errors in sequence entry, but in annotation of the
sequence in the FEATURES table of the corresponding entry.
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In some cases the search used by Shapiro et al misinterpreted
correct annotations, but on the whole the FEATURES table was
in error. These are not necessarily errors on the part of the
database staff, but may again be faulty communication of features
to the databases.
Are there any particular characteristics of the consensus
sequences around the bone fide variant sites? There are too few
sequences with variants of the 3' AG to generalise, but all four
are pyrimidine rich in the intron, as is the consensus. All four
are alternative splice sites.
Almost all the 5' variant sites have the GT dinucleotide at the
first two bases of the intron replaced by GC. In vitro studies have
shown that this substitution is the only one which will still allow
the 5' site to be accurately cleaved. albeit more slowly than the
usual GT sequence (27). The rest of the sequences of the 5' GC
as a whole are significantly different from the usual GT sites.
The surrounding sequences show a greater match to the prototype
sequence (and therefore have greater complementarity to Ul
RNA) than the average consensus splice. At base -1 (i.e. the
last base of the exon) this group match the prototype G in 96%
of cases, compared to 79% of all GT splices. At -2, 88% have
the prototype A, compared with only 60% of GT sites. Within
the intron at base +3, 80% of the GC sites have A; only 59%
ofGT splices have this base. At +4 the A is in 84% of GC sites
and 71% of GT and at +5 the G is found in 100% of this group
but in 82% of all GT splice sites.
Jacob and Gallinaro (4) have shown that mismatches between
the splicing substrate and Ul RNA can be tolerated in splice sites
either 5' or 3' of the cleavage site, but not both. The better
consensus match of the GC variant splices can be explained by
the pairing requirement with Ul RNA in the spliceosome, which
is lacking the usual central U:A pair from the GT sequence, and
so needs a better match from the rest of the sequence. This
observation might be useful as an addition to the normal sequence
matrix for identifying splice sites in uncharacterised DNA
sequences.
I have also noted here two genes with very unusual sequences
at both ends of one intron. Although the genes are completely
unrelated, the sequences at the ends of the introns are strikingly
similar. Both introns begin ATATCC and end PyPyCAC. It is
possible that these splice sites indicate a novel (and presumably
rare) splice mechanism.
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